-The Times of India NEW DELHI: Various drug price regulatory measures by the government helped consumers save Rs 4,988 crore over the last two years, Rajya Sabha was told on Thursday. Following approval of the pharmaceutical pricing policy in 2012, the government has capped prices of essential medicines at least three times since 2013, when the policy was first implemented by the National Pharmaceutical Pricing Authority through the Drugs Price Control Order...

-PTI Prices of 42 essential medicines used in treatment of various ailments including tuberculosis, cancer, cardiac diseases, asthma, epilepsy and depression have been capped by the government, reducing their cost by up to 15 per cent. Drug price regulator, National Pharmaceutical Pricing Authority (NPPA), in a notification on its website, said it “has fixed/revised ceiling prices of 45 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016.” “Out of the 45,...

-The Times of India NEW DELHI: Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has slashed prices of 54 essential medicines by up to 55%, including commonly used drugs for cancer (brain and breast), hypertension, diabetes, antibiotics and other heart disorders. The move is aimed at bringing down prices of commonly used drugs for critical diseases by expanding span of price regulation to cover new drugs, NPPA Chairman Bhupinder Singh told TOI. In...

-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...

-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...